Overview

A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure

Status:
Completed
Trial end date:
2007-06-08
Target enrollment:
Participant gender:
Summary
This study will be conducted in healthy volunteers to investigate the effect on intraocular pressure of 2 weeks of treatment with 300mg WELLBUTRIN XL/day.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Bupropion